The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Armo Biosciences Inc | COM | 04225U104 | 13,969 | 413,892 | SH | SOLE | 1 | 413,892 | 0 | 0 | |
OraSure Technologies Inc | COM | 68554V108 | 1,981 | 117,291 | SH | SOLE | 1 | 117,291 | 0 | 0 | |
Agenus Inc | COM NEW | 00847G705 | 43,867 | 9,313,556 | SH | SOLE | 1 | 9,313,556 | 0 | 0 | |
Arbutus Biopharma Corp | COM | 03879J100 | 25,758 | 5,151,615 | SH | SOLE | 1 | 5,151,615 | 0 | 0 | |
PTC Therapeutics Inc | COM | 69366J200 | 111,973 | 4,137,960 | SH | SOLE | 1 | 4,137,960 | 0 | 0 | |
Dicerna Pharmaceuticals Inc | COM | 253031108 | 48,082 | 5,029,462 | SH | SOLE | 1 | 5,029,462 | 0 | 0 | |
Viewray Inc | COM | 92672L107 | 8,737 | 1,358,711 | SH | SOLE | 1 | 1,358,711 | 0 | 0 | |
Myokardia Inc | COM | 62857M105 | 12,672 | 259,670 | SH | SOLE | 1 | 259,670 | 0 | 0 | |
La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 33,429 | 1,122,540 | SH | SOLE | 1 | 1,122,540 | 0 | 0 | |
Uniqure NV | SHS | N90064101 | 9,557 | 406,667 | SH | SOLE | 1 | 406,667 | 0 | 0 | |
CORIUM INTL INC | COM | 21887L107 | 21,914 | 1,910,522 | SH | SOLE | 1 | 1,910,522 | 0 | 0 | |
MOTUS GI HLDGS INC | COM | 62014P108 | 531 | 118,478 | SH | SOLE | 1 | 118,478 | 0 | 0 | |
Homology Medicines Inc | COM | 438083107 | 4,208 | 225,000 | SH | SOLE | 1 | 225,000 | 0 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 2,048 | 25,457 | SH | SOLE | 1 | 25,457 | 0 | 0 | |
Avexis Inc | COM | 05366U100 | 29,217 | 236,425 | SH | SOLE | 1 | 236,425 | 0 | 0 | |
PROTEOSTASIS THERAPEUTICS IN | COM | 74373B109 | 5,248 | 1,104,940 | SH | SOLE | 1 | 1,104,940 | 0 | 0 | |
Nuvectra Corp | COM | 67075N108 | 6,602 | 507,061 | SH | SOLE | 1 | 507,061 | 0 | 0 | |
CareDx Inc | COM | 14167L103 | 4,468 | 560,600 | SH | SOLE | 1 | 560,600 | 0 | 0 | |
Adverum Biotechnologies Inc | COM | 00773U108 | 1,016 | 175,208 | SH | SOLE | 1 | 175,208 | 0 | 0 | |
Novus Therapeutics Inc | COM | 67011N105 | 1,512 | 300,000 | SH | SOLE | 1 | 300,000 | 0 | 0 | |
VIVEVE MED INC | COM NEW | 92852W204 | 9,361 | 2,557,559 | SH | SOLE | 1 | 2,557,559 | 0 | 0 | |
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 22,069 | 456,921 | SH | SOLE | 1 | 456,921 | 0 | 0 | |
Regenxbio Inc | COM | 75901B107 | 56,051 | 1,877,767 | SH | SOLE | 1 | 1,877,767 | 0 | 0 | |
LivaNova PLC | SHS | G5509L101 | 12,390 | 140,000 | SH | SOLE | 1 | 140,000 | 0 | 0 | |
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 69,346 | 1,096,386 | SH | SOLE | 1 | 1,096,386 | 0 | 0 | |
Edwards Lifesciences Corp | COM | 28176E108 | 20,265 | 145,246 | SH | SOLE | 1 | 145,246 | 0 | 0 | |
Vericel Corp | COM | 92346J108 | 20,576 | 2,067,916 | SH | SOLE | 1 | 2,067,916 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 29,326 | 246,229 | SH | SOLE | 1 | 246,229 | 0 | 0 | |
Novavax Inc | COM | 670002104 | 5,726 | 2,726,504 | SH | SOLE | 1 | 2,726,504 | 0 | 0 | |
ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 50,074 | 13,496,902 | SH | SOLE | 1 | 13,496,902 | 0 | 0 | |
Bovie Medical Corp | COM | 10211F100 | 5,738 | 1,931,948 | SH | SOLE | 1 | 1,931,948 | 0 | 0 | |
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 21,028 | 2,916,561 | SH | SOLE | 1 | 2,916,561 | 0 | 0 | |
Sarepta Therapeutics Inc | COM | 803607100 | 50,994 | 688,271 | SH | SOLE | 1 | 688,271 | 0 | 0 | |
Masimo Corp | COM | 574795100 | 20,404 | 232,000 | SH | SOLE | 1 | 232,000 | 0 | 0 | |
Odonate Therapeutics Inc | COM | 676079106 | 5,303 | 274,544 | SH | SOLE | 1 | 274,544 | 0 | 0 | |
Rocket Pharmaceuticals Inc | COM | 77313F106 | 258,228 | 14,969,744 | SH | SOLE | 1 | 14,969,744 | 0 | 0 | |
Solid Biosciences Inc | COM | 83422E105 | 4,612 | 675,771 | SH | SOLE | 1 | 675,771 | 0 | 0 | |
VIVUS INC | NOTE 4.500% 5/0 | 928551AB6 | 2,500 | 4,000,000 | SH | SOLE | 1 | 4,000,000 | 0 | 0 |